4183. Misbranding of dextro-amphetamine sulfate tablets and pentobarbital sodium capsules. U. S. v. Paul B. Ginther (Central Drug Co.). Plea of guilty. Fine of $625, plus costs.

Name: 4183. Misbranding of dextro-amphetamine sulfate tablets and pentobarbital sodium capsules. U. S. v. Paul B. Ginther (Central Drug Co.). Plea of guilty. Fine of $625, plus costs.
Creator: National Library of Medicine
Published: 2026-06-21T06:45:09+08:00

Food and Nutrition Information Center2026-06-21 收录

药品标签合规

药物监管执法

数据链接：

https://fdanj.nlm.nih.gov/catalog/ddnj04183 数据链接链接失效反馈

官方服务：

资源简介：

Case Number: 4183 Collection: Drugs and Devices, 1940-1963 Evidence Numbers: F. D. C. No. 35101. Sample Nos. 48446-L, 48457-L to 48460-L, incl. Date Issued: August 1954 Seizure Dates: October 20; November 14 and 15, 1952 Product Keywords: dextroamphetamine sulfate tablets and pentobarbital sodium capsules Defendant Names: Paul B. Ginther, trading as the Central Drug Co., Clinton, Iowa. Court Jurisdiction: Southern District of Iowa Seizure Location: Clinton, Iowa. Shipped From: Clinton, Iowa. Shipped To: Clinton, Iowa. Copyright: The National Library of Medicine believes this item to be in the public domain (More information)

提供机构：

National Library of Medicine

4183. Misbranding of dextro-amphetamine sulfate tablets and pentobarbital sodium capsules. U. S. v. Paul B. Ginther (Central Drug Co.). Plea of guilty. Fine of $625, plus costs.

资源简介：

相关数据集